Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey.
Repository Usage Stats
OBJECTIVES: The utility value attributed to taking pills for prevention can have a major effect on the cost-effectiveness of interventions, but few published studies have systematically quantified this value. We sought to quantify the utility value of taking pills used for prevention of cardiovascular disease (CVD). DESIGN: Cross-sectional survey. SETTING: Central North Carolina. PARTICIPANTS: 708 healthcare employees aged 18 years and older. PRIMARY AND SECONDARY OUTCOMES: Utility values for taking 1 pill/day, assessed using time trade-off, modified standard gamble and willingness-to-pay methods. RESULTS: Mean age of respondents was 43 years (19-74). The majority of the respondents were female (83%) and Caucasian (80%). Most (80%) took at least 2 pills/day. Mean utility values for taking 1 pill/day using the time trade-off method were: 0.9972 (95% CI 0.9962 to 0.9980). Values derived from the standard gamble and willingness-to-pay methods were 0.9967 (0.9954 to 0.9979) and 0.9989 (95% CI 0.9986 to 0.9991), respectively. Utility values varied little across characteristics such as age, sex, race, education level or number of pills taken per day. CONCLUSIONS: The utility value of taking pills daily in order to prevent an adverse CVD health outcome is approximately 0.997.
medical decision making
Attitude to Health
Drug Administration Schedule
Quality of Life
Published Version (Please cite this version)10.1136/bmjopen-2014-006505
Publication InfoHutchins, Robert; Pignone, Michael P; Sheridan, Stacey L; & Viera, Anthony J (2015). Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey. BMJ Open, 5(5). pp. e006505. 10.1136/bmjopen-2014-006505. Retrieved from https://hdl.handle.net/10161/15925.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Consulting Associate in the Department of Medicine
Professor of Family Medicine and Community Health
My major area of research is cardiovascular disease prevention. I am particularly interested in improving detection and control of hypertension. Since assessment of blood pressure begins with measurement, my studies often include out-of-office BP measurement techniques including 24-hour ambulatory BP monitoring and home BP monitoring. I am also interested in obesity prevention, and in another line of research am examining the effectiveness of food labeling policies (such as calorie-l
Alphabetical list of authors with Scholars@Duke profiles.